The adenovirus early region 1B (Ad E1B) genes have no transforming capability of their own but markedly increase the transformation frequency of Ad E1A following co-transfection into mammalian cells. The larger E1B proteins of both Ad2/5 and Ad12 bind to p53 and inhibit its ability to transcriptionally activate other genes. We have previously demonstrated that synthetic peptides identical to the binding sites for p53 on both the Ad2 and Ad12 E1B proteins will disrupt the interaction in vivo and in vitro. In the work presented here we have examined the eects of complex dissociation on Ad E1-transformed human cells. It has been shown, using confocal microscopy, that when the peptide identical to the p53 binding site was added to Ad5 E1-transformed cells it initally located in the cytoplasmic dense bodies where it caused disruption of the p53/E1B complex. Peptide and p53 then translocated to the nucleus. In Ad12 E1-transformed cells the peptide localized in the nucleus directly and there caused a reorganization of p53 staining from a highly organized,¯e cked' distribution to one in which nuclear staining was homogeneous and diuse. Peptides added to either Ad5 E1 or Ad12 E1 transformed cells resulted in the release of transcriptionally active p53. Interestingly, the level of p53 then fell presumably as a result of proteasomal action -this was probably a re¯ection of the short halflife of`free' (i.e. dissociated) p53 compared to that of the bound protein. Free p53 did not cause apoptosis in target cells probably due to the presence of the smaller (19K) E1B proteins. However, addition of peptide leads to a signi®cant reduction in cell growth rate. We have further demonstrated that a signi®cant proportion of those cells which had taken up peptide had ceased DNA synthesis, probably due to a p53-induced cell cycle arrest. The role of the larger E1B protein during transformation is considered in view of these data. Oncogene (2000) 19, 452 ± 462.
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Introduction
It has long been established that expression of the adenovirus early region 1A (Ad E1A) proteins is essential for adenovirus-mediated transformation and that the frequency of transformation is dramatically increased by co-expression of the Ad E1B proteins (reviewed Bernards and van der Eb, 1984; Gallimore et al., 1985a) . Ad E1A exerts its in¯uence on the recipient cell by means of a series of protein-protein interactions. Many of these binding proteins are involved in the regulation of transcription in the target cell ± for example the pRb family of proteins, p300/CBP, Tata binding protein (TBP) and the C terminal binding protein (CtBP) (reviewed Bayley and Mymryk, 1994; Moran, 1994 ). An additional eect of Ad E1A, both in infected and transfected cells is to increase the level of expression of p53 (Lowe and Ruley, 1993; Debbas and White, 1993; Grand et al., 1994) . This property is dependent on the integrity of conserved regions (CR) 1 and 2 and requires binding of E1A to pRb and p300 (Querido et al., 1997; Chiou and White, 1997; Thomas and White, 1998) . Recent evidence has indicated that the up-regulation of p53 by Ad E1A is mediated through p19
ARF (de Stanchina et al., 1998) . It has been suggested that the major role of Ad E1B proteins is to neutralize the eect of the increased levels of p53, thus inhibiting apoptosis (White, 1996 (White, , 1998 . The two major Ad E1B proteins can produce this eect either separately or together (Rao et al., 1992) . Ad E1B 19K is a Bcl-2 homologue and appears to function in an analogous manner, binding to Bax and other functional homologues and neutralizing their proapoptotic properties (reviewed White, 1996 White, , 1998 Chinnadurai, 1998) .
In transformed cells the larger Ad E1B proteins ± 54K in Ad12 and 58K in Ad2 and Ad5±function by binding directly to p53 such that it is transcriptionally inactivated (Yew and Berk, 1992) . Whilst Ad E1B 54K and 58K proteins share the ability to neutralize p53 there are a number of striking dierences between them. The Ad2/5 proteins bind p53 strongly (Sarnow et al., 1982; Zantema et al., 1985a) with the p53/Ad E1B complex being localized to cytoplasmic dense bodies in Ad2/5 E1-transformed cells (Zantema et al., 1985b; Blair-Zejdal and Blair, 1988) . In contrast, Ad12 E1B 54K interacts with p53 only weakly (Grand et al., 1994) . p53 and much of the E1B 54K protein is in the nucleus in Ad12 E1-transformed cells, although some of the viral protein localizes diusely to the cytoplasm (Zantema et al., 1985b; Mak et al., 1988) . The nuclear location of p53 and Ad12 E1B 54K protein may be attributable to the presence of a possible nuclear localization signal on the Ad12 E1B protein which is absent from the Ad2/5 homologue . Despite these dierences the binding sites for p53 on the Ad2 and Ad12 E1B proteins have recently been mapped to homologous sites located in the centre of the molecules (between amino acids 216 and 235 in Ad2 and between amino acids 202 and 221 in Ad12) . During the course of that study the identity of the proposed p53 binding site was con®rmed using`trojan peptides' (Prochianz, 1996; Derossi et al., 1998) to disrupt the interactions. Thus, peptides identical to the binding sites on the Ad E1B proteins were synthesized linked to the penetratin-1 sequence so that when they were added to tissue culture medium they would rapidly enter cells (Derossi et al., 1998) . These peptides disrupted Ad E1B/p53 complexes both in vivo and in vitro .
The study described here is a continuation of that work in which we have gone on to analyse the eects for the recipient Ad E1-transformed cell of the disruption of the Ad E1B/p53 complex. It has been demonstrated that addition of peptide to Ad5 E1 transformants causes translocation of p53 to the nucleus, release of transcriptionally active p53 in both Ad5 and Ad12 E1-transformed cells, as well as a reduction in cell growth and DNA synthesis due to cell cycle arrest, induced by p53.
Results
It has previously been shown that synthetic peptides identical to the p53 binding site on Ad12 E1B 54K protein or Ad2/5 E1B 58K protein will compete with the intact protein for p53 reducing the concentration of complex both in vivo and in vitro . Peptides 1507 and 1508 (equivalent to the Ad12 E1B 54K and Ad5 E1B 58K binding site, respectively) were added to a lysate of Ad5 E1 HEK 293 cells. The larger E1B protein was immunoprecipitated and bound p53 detected by Western blotting. It can be seen from the data presented in Figure 1 that whilst the concentration of complex was reduced in the presence of peptide it was not totally dissociated, as described previously . Similar results were obtained when Ad12 E1 HER cells were treated with peptides 1507 and 1508 (equivalent to the Ad5 and Ad12 sequences [data not shown and Grand et al., 1999] ). The consequences for Ad E1-transformed cells of disruption of the complex are examined in the work presented below.
Eect of peptides on the localization of p53 in Ad E1-transformed cells
To investigate to what extent the subcellular localization of p53 and the Ad E1B proteins was in¯uenced by complex formation, confocal microscopy has been used to follow the peptides and proteins. Initially, to examine the stability of peptides in the cell lines, peptide 1507 was synthesized with an FITC moiety located at the C-terminus. Confocal microscopy showed that the peptide localized to the nucleus of Ad12 E1 HER2 cells within 12 h (Figure 2 , panel M) and remained there at high concentration (as shown in panel P) for up to 96 h (data not shown). We presume this re¯ects the stability of the peptide since free FITC was not retained in cells after ®xing (data not shown). The FITC-labelled peptide was equally stable in Ad5 E1 HEK 293 cells (panels D and G).
When FITC-1507 peptide was added to Ad5 E1 HEK 293 cells it initially localized to the cytoplasmic dense bodies (at 6 h and 12 h) together with p53 (Figure 2 panels A, C, D and F ± co-localization is shown in panels B and E in yellow). By 24 h, however, the peptide seems to have dissociated much of the E1B 58K/p53 cytoplasmic complex so that the p53 (together with the FITC-labelled peptide) had translocated into the nucleus ± as seen in panels G, H and I. This distribution did not change over the next 48 h (data not shown). When peptide was introduced into Ad12 E1 HER2 cells nuclear localization was more rapid than in the Ad5 transformants (compare panels D and M). Twelve hours after addition the peptide colocalized in the nucleus with the p53 in large`¯ecks' (panels M, N and O). Similar large¯ecks were seen in some nuclei of Ad5 E1 HEK 293 cells treated with peptide (for example, the central nucleus in panel I). At later times (e.g. 24 h) in the Ad12 E1 transformants distribution of p53 became homogeneous as was the FITC-labelled peptide. Thus, in panel R p53 staining in the lower nucleus remains quite punctate and is concentrated into¯ecks (as in cells with no peptide added ± data not shown) ± due to the fact that no peptide enters that cell (compare panel P). However, in cells which take up appreciable amounts of peptide (e.g. the upper cell in panels P, Q and R), homogeneous nuclear localization of p53 and peptide can be seen. In cells which do not express the Ad12 E1B 54K protein p53 staining in the nucleus is homogeneous both in the absence or presence of peptide (data not shown).
In a further set of experiments, peptides (with no FITC label) were added to Ad12 and Ad5 E1 transformants and stained for the larger E1B proteins (Figure 3 ). It can be seen that there was a similar relocalization of p53 to that seen in Figure 2 . Interestingly, the Ad5 E1B protein remained in the cytoplasm after addition of peptide, even though much of the p53 became nuclear (Figure 3 ). These data, taken together, con®rm that the binding of the Ad E1B protein is critical in determining the location of p53 in Ad5 E1 transformants. Further experiments were carried out to look for changes in the properties of p53 and the cells when the E1B/p53 complex was dissociated.
p53 transcriptional activation
The transcriptional activating ability of p53 in Ad E1-transformed cells treated with`E1B peptides' was Figure 3 The eect of p53 binding site peptide on the distribution of p53 and Ad E1B protein in Ad E1-transformed human cells. Cells were grown on microscope slides, treated with peptide 1507 for 24 h and then ®xed as described in the Materials and methods. p53 was detected using the antibody 1801 and Ad12 E1B 54K protein and Ad5 E1B 58K protein were detected using XPH9 and 2A6 respectively. Antigens were visualized by confocal microscopy. Panels A-F, Ad5 E1 HEK 293 cells; panels G-L, Ad12 E1 HER2 cells. Panels A, D, G and J stained for Ad E1B protein; panels C, F, I and L stained for p53. Panels A ± C and G ± I show untreated, control cells. Panels D ± F and J ± L show cells after incubation with peptide. Panels B, E, H and K show`merged' images of those panels on either side investigated. Thus Ad5 E1 HEK 293 cells and Ad12 E1 HER2 cells were transfected with a p53-responsive CAT reporter construct. Peptides 1507 or 1508 were added to the cells in culture. Cells were harvested at appropriate times and p53 transcriptional activity determined (see Materials and methods). Eciency of transfection was checked using a luciferase-containing plasmid. The eect of peptides 1507 and 1508 on the p53 transcriptional activity in Ad5 E1 HEK293 cells and Ad12 E1 HER2 transformed human cells is shown in Figure 4a . It can be seen that over the 48 h time course there was an appreciable increase in transcriptionally active p53 in cell lines expressing either the Ad5 or Ad12 E1B proteins (Figure 4a ). This was most marked for the Ad12 E1-transformed cells treated with peptide 1507 (equivalent to the Ad12 E1B 54K sequence). However, in all cases p53 transcriptional activation increased. This study was expanded so that the eects of the peptides on other Ad-transformed and non-adenovirus expressing cells could be ascertained (Figure 4b ). There was no eect on human tumour cell lines such as A549 or, more interestingly, on SV40-transformed cells. Whilst SV40 T antigen binds strongly to p53 the binding sites are quite distinct from those present on the Ad E1B proteins ± thus it would not be expected that peptides 1507 and 1508 would compete for the binding site, nor disrupt the complex nor increase the level of transcriptionally active p53. However, it was noted that both peptides dissociated Ad E1B/p53 complexes in Ad12 E1B 54K + mouse embryo ®broblasts leading to an increase in transcriptionally active p53 (Figure 4b [ii] and data not shown). Most marked of all was the eect of the peptides on Ad12 E1 HER10 cells where peptide 1507 caused an increase of over tenfold in p53 activity ( Figure 4b [iii]).
p53 expression
It has previously been shown that p53 half-life is appreciably increased in Ad E1-transformed cells, compared to normal cells (van den Heuval et al., 1990; Grand et al., 1993) . It seems likely that both Ad E1A and the large E1B proteins exert an eect on p53 half-life (Grand et al., 1996) . To examine the eect of dissociation of p53/Ad E1B complex the levels of p53 were determined, by Western blotting, in cells treated with peptides 1507 and 1508 ( Figure 5 ). There was a marked reduction in level of p53 in Ad12 and Ad5 transformants (HER2 and 293 cells respectively) as the experiment progressed, presumably re¯ecting the disparity in half-life between`normal' cells and those expressing Ad E1B proteins. Thus, release of p53 from the complex probably means that it is more susceptible to proteasomal degradation. No dierence was observed in expression of Ad E1A (data not shown) or of the larger Ad E1B proteins ( Figure 5 ) after treatment of cells with peptides. Similarly, no dierence was observed in the p53 level in mock-treated Ad E1 transformed cells (data not shown). Preliminary studies have shown that addition of peptide to Ad5 E1-transformed cells results in an increase in level of Mdm2, presumably due to the increase in p53 transcriptional activity (Figure 4) . It seems likely that the additional Mdm2 may play a part in the observed rapid degradation of p53 ( Figure 5) .
Role of the Ad E1B/p53 complex in cell growth in Ad E1-transformed cells It has already been shown that the E1B peptides dissociate E1B/p53 complexes (Figure 1 and and that the free p53 is transcriptionally active (Figure 4 ). The eect of this`liberated protein' on the growth potential of Ad E1-transformed cells was examined. Under normal circumstances p53 controls G1/S and G2/M checkpoints, although p53 7/7 animals are viable, suggesting redundancy in checkpoint control. In normal circumstances, however, p53 plays its most signi®cant role during the cellular response to DNA damage when the level of the protein increases rapidly. This causes cell cycle arrest (usually in G1 or G2) allowing repair or apoptosis to take place, depending on the extent of the damage.
When peptides 1507 and 1508 were added to Ad12 E1 HER2 and Ad5 E1 HEK 293 cells there was an appreciable reduction in growth rate (Figure 6 ). For example, the number of Ad5 E1 HEK 293 cells in a culture had increased almost threefold in the absence of peptide and 1.8-fold in the presence of peptides. Both peptides had very similar eects in the Ad5 and Ad12 transformants. This is consistent with data presented here and previously which shows that there is relatively little dierence between the Ad5 E1B 58K and Ad12 E1B 54K protein binding sites for p53.
Since there was a marked reduction in growth rate of Ad E1-transformed cells in the presence of E1B peptides, we reasoned that disruption of the E1B/p53 complex and liberation of p53 might impact directly on the cell cycle. To investigate this possibility Ad5 E1 HEK 293 cells, grown on slides, were treated with E1B peptide for 24 h. Thirty minutes prior to harvesting, cells were pulsed with 50 mM BrdU, in order to distinguish between cells in S phase and synthesizing DNA and those cells not replicating their DNA. Cells were ®xed and permeabilized and then stained for both p53 and BrdU; antigens were visualized by confocal microscopy (see Materials and methods). Initially, immuno¯uorescence microscopy revealed that the E1B/p53 complex was fully dissociated in approximately 23% of cells as indicated by the redistribution of p53 from the cytoplasm to the nucleus (Figure 7 ). Immuno¯uorescence also revealed there was a mixed population of cells that possessed both cytoplasmic and nuclear staining patterns, suggesting that in those cells Figure 5 p53 expression in Ad E1 cell lines in response to synthetic E1B peptides. Ad12 E1 HER2 and Ad5 E1 HEK 293 cells were treated with peptides 1507 and 1508. After various times cells were harvested and subjected to Western blotting using antibodies against p53 and Ad E1B proteins. The upper half of the ®gure shows the Western blots obtained. These blots were scanned using a BioRad densitometer and values obtained were plotted in the lower half of the ®gure. Ad12 E1 HER2 and peptide 1507, -^-; Ad12 E1 HER2 cells+peptide 1508; -&-Ad5 E1 HEK 293 cells+peptide 1507, X; Ad5 E1 HEK 293 cells+peptide 1508, -~-only a proportion of the E1B/p53 complex had been dissociated. Furthermore, there was a proportion of cells where the p53/E1B complex remained intact, and therefore cytoplasmic. This heterogeneous pattern of p53 distribution might explain the incomplete cessation of growth upon addition of E1B peptides to cells shown in Figure 6 .
The staining pattern of p53 was then related to the cell cycle status of the cell. In cells where the E1B/p53 complex was still intact and cytoplasmic, 52% of cells were BrdU positive (Figure 7) . However, in cells where the E1B/p53 complex had been completely disrupted and p53 had translocated to the nucleus, only 25% of these cells (i.e. 5% of the total) were BrdU-positive (Figure 7ii ). This reduction of BrdU-positive cells where the E1B/p53 complex has been disrupted presumably re¯ects the increase in transcriptional activity of p53 following liberation from the complex and speci®c induction of target gene products preventing cells from entering S phase.
Thus, we conclude that disruption of the E1B/p53 complex allows transcriptional activation of p53, which, in the presence of anti-apoptosis E1B 19K, induces a cell cycle-speci®c block. In the context of transformation, these data suggest that E1B 58K can speci®cally overcome Ad E1A-induced, p53-dependent cell cycle arrest pathways, whereas E1B-19K inhibits p53-dependent apoptosis.
Discussion
The major adenovirus transforming protein is E1A (reviewed, Bayley and Mymryk, 1994) . However, it is clear that frequency of transformation is dramatically increased by the additional expression of the E1B proteins. Simplistically, it has been suggested that this is because they neutralize p53-induced apoptosis, p53 expression having been increased by E1A (Debbas and White, 1993; Lowe and Ruley, 1993; Grand et al., 1994) . The smaller Ad E1B protein (19K) acts in the same fashion as Bcl-2 but the larger proteins have quite distinct properties, being able to inhibit the transcriptional activation properties of p53 ± probably through direct binding (Yew and Berk, 1992; Yew et al., 1994) . However, it is now becoming clear that the mode of action of Ad12 E1B 54K and Ad5 E1B 58K proteins during transformation may well be rather more complex. For example, it has recently been shown that E1B binding proteins, other than p53, can be isolated (Gabler et al., 1998) . Furthermore, it has been demonstrated that Ad12 E1B 54K protein can have quite profound eects on the growth characteristics of human cells in culture in the absence of other adenovirus proteins i.e. when there is no requirement to protect from p53-induced apoptosis (Gallimore et al., 1997) . In the light of these observations, we felt that it was of considerable interest to examine the eect on Ad E1-transformed cells of disruption of the complex between p53 and Ad E1B. This would allow us to see whether the interaction with p53 only had an anti-apoptosis role or whether it had additional eects on the growth properties of Ad E1 transformants.
We have previously shown that the E1B/p53 complex can be eciently, altough not entirely, disrupted by the addition of a peptide identical to the p53 binding site linked to the penetratin sequence to facilitate entry into the cell . The peptide appears to be stable for long periods when introduced into cells, such that FITC-labelled peptide 1507 could still be detected within cells several days after addition to culture medium (Figure 2 ). (It is unlikely that the micrographs presented in Figure 2 represent free FITC remaining after peptide degradation as FITC added to cells was washed out during ®xing procedures).
Confocal microscopy has facilitated the analysis of how the synthetic peptides aect the subcellular localization of p53 and the larger E1B proteins in Ad E1 transformants. By 12 h after addition of peptide to either Ad12 or Ad5 E1 transformed cells appreciable co-localization with p53 was observed either in the nucleus or cytoplasm, as appropriate (Figure 2 ). This peptide then had the eect of causing the relocalization of p53. In the case of Ad5 E1-expressing cells this was from the cytoplasmic dense bodies to the nucleus but in the case of the Ad12 E1-containing cells this could be seen as a relocalization within the nucleus (from concentrated¯ecks to a much more homogeneous distribution [ Figures 2 and  3] ). Therefore it appears that the larger Ad E1B proteins govern both the activity (or rather lack of it) and location of p53 in E1 transformants. The nuclear ecks seen in Ad12 E1-containing cells have been observed previously , and may represent the Ad12 equivalent of the Ad5 cytoplasmic dense bodies. After disruption of the complexes with p53 Ad5 E1B 58K protein remains in the cytoplasm, whilst the Ad12 protein remains in the nucleus, consistent with the presence of a NLS only in the latter protein . At present it is not clear why this dierence exists between equivalent proteins from the two viral serotypes but it may re¯ect more profound dierences in the structure and function of the E4orf6 proteins. Thus, in Ad5 infected cells binding of E4orf6 34K protein to E1B 58K is necessary for it to function correctly in the regulation of late viral RNA metabolism and speci®cally to localize the E1B protein to the nucleus (Dobbelstein et al., 1997) . In view of the NLS on Ad12 E1B 54K binding to the appropriate E4orf6 protein may not be required. Resolution of this point will have to await further investigation.
p53 released from complexes with E1B proteins is transcriptionally active, being able to stimulate a p53-reporter construct (Figure 4a ). Whether this p53 is able to interact with TBP causing transcriptional repression is unclear but it seems likely as the protein appears to behave normally in many respects (i.e. like wt). The observation that the peptide could release transcriptionally active p53 in both Ad5 and Ad12 cells is consistent with the original report by Yew and Berk (1992) which showed that both Ad5 E1B 58K protein and Ad12 E1B 54K protein would inhibit p53 activity despite the fact that complexes between p53 and Ad12 E1B 54K protein were demonstrable only to a limited extent (Grand et al., 1994) .
Whilst the abilities of the two peptides to disrupt both Ad5E1B and Ad12E1B/p53 complexes in vitro were similar (Figure 1 and Grand et al, 1999) dierences were observed in the in vivo experiments described here. Thus, as a rule peptides were more ecient at disrupting the complex in Ad12 transformed cells than in Ad5 (compare Figure 4b , panels [ii] and [iii] ). This result might be expected if the anity of p53 for Ad12 E1B 54K is less than that for Ad5 E1B 58K as appears to be the case. Furthermore, the peptide 1507 (equivalent to the Ad12 E1B 54K sequence) is rather more ecient in disruption of the complexes i Figure 7 S phase status of Ad5 E1 HEK 293 cells treated with E1B peptide. Cells grown on glass coverslips were cultured in the presence of peptide (100 mg/ml) for 24 h. Thirty minutes prior to ®xing, cells were incubated with 50 mM BrdU to label nascently synthesized DNA. Cells were ®xed, permeabilized and dual stained for p53 (red staining) and BrdU (green staining) and antigens visualized by immuno¯uorescence (i) (see Materials and methods). Both cytoplasmic and nuclear p53 staining, indicative of E1B/p53 complex association and dissociation, respectively, was correlated to the S phase (BrdU) status of the cell (ii). Typically, in one experiment, the BrdU-staining pattern was recorded in 500 cells possessing nuclear p53, and 500 cells possessing cytoplasmic p53. Data shown is mean from two independent experiments. The open columns indicate the proportion of cells with nuclear or cytoplasmic p53 after addition of peptide as indicated. The shaded columns show the proportion of cells with either cytoplasmic (left-hand columns) or nuclear p53 (right-hand columns) which were BrdU positive ± i.e. undergoing DNA synthesis than peptide 1508 (Ad2/5 E1B 58K sequence). This is rather surprising as it might be expected that the Ad5 peptide would have a higher anity for p53. This point is currently under investigation.
Interestingly, no apoptosis was observed following addition of peptides. We presume that the smaller Ad E1B proteins protect from cell death. Indeed, it has previously been demonstrated that the E1B 19K component is a somewhat more potent anti-apoptosis agent than the larger E1B protein (Rao et al., 1992) . Moreover, expression of E1B 19K by large E1B-null mutant adenoviruses overcomes an abortive infection by inhibiting premature Ad-induced apoptosis, and thus facilitating viral replication (Turnell et al., 1999) .
Addition of peptides and consequent complex disruption has the eect of reducing the replicative capacity of Ad5 and Ad12 E1 transformed cells ( Figure  6 ). It is likely that this is directly attributable to the dissociation of the p53/E1B complex. This is largely consistent with our previous observation that the expression of Ad12 E1B 54K protein could increase the lifespan of human cells in culture (Gallimore et al., 1997) . It was concluded in that study that the binding of p53 by the viral protein was directly responsible for the change in growth properties. Therefore, it seems reasonable to assume that disruption of E1B/p53 complexes would have an opposite eect ± limiting cell growth. Cell cycle analysis on populations of Ad5 and Ad12 E1 transformed cells showed little eect of the synthetic peptides. However, when cells were examined individually by confocal microscopy ( Figure 7 ) it was seen that those containing peptide, which caused translocation of p53 from the cytoplasmic dense bodies to the nucleus, were signi®cantly impaired in their ability to synthesize DNA. We conclude, on the basis of these data, that the larger Ad E1B proteins do not simply play an anti-apoptotic role in transformed cells but also ablate the ability of p53 to induce cell cycle arrest. Thus, eects of the high concentrations of p53 which largely result from Ad E1A expression in transformed cells are neutralized in quite distinct ways by the E1B proteins. The apoptosis-inducing properties are countered by the increase in level of the antiapoptotic Bcl-2 homologue ± the E1B 19K protein. The ability of p53 to induce cell cycle arrest is overcome by the larger E1B protein. This may be more important during transformation of human than rodent cells. Thus, it is relatively straightforward to isolate transformed rodent cell lines after transfection of DNA encoding E1A and the E1B 19K protein (Gallimore et al., 1985b) whereas no human lines which do not also express the larger E1B protein have been isolated (Gallimore et al., 1986) . Overcoming the cell cycle arrest properties of p53 must be particularly signi®cant in the establishment of the human lines. It is of course possible that other properties of the larger Ad E1B proteins are also important in this case.
It is also possible that the larger Ad E1B proteins play a speci®c role in reducing the tendency of cells to senesce. Indeed, it has already been shown that expression of the Ad12 E1B 54K protein (in the absence of other viral proteins) increases the life span of human cells in culture by several-fold (Gallimore et al., 1997) . Whether this`anti-senescence' property is necessary for the establishment of transformed cell lines will have to await further investigation.
Materials and methods

Cell lines
Ad12 E1 human embryo retinoblast (HER)2 and Ad12 E1 HER10 cell lines were produced by transfection of Ad12 E1 DNA into human embryo retinoblasts (Gallimore et al., 1986) and express E1A and E1B proteins. Ad5 E1 HEK293 and Ad5 HER 911 cells express the full complement of Ad5 E1 proteins. A549 cells derive from a human small cell lung carcinoma, COS cells are monkey kidney epithelial cells transformed with SV40. Cells were grown in DMEM supplemented with 8% foetal calf serum and 2 mM glutamine.
Cell growth determinations
Cells were grown in the presence or absence of`Ad E1B peptides' (see below). At the allotted time points cells were harvested and subjected to Western blotting, immunofluorescence microscopy or were counted to assess cell growth.
Determination of p53 transcriptional activation activity
To determine transcriptional activity of p53 cells were transfected with a CAT reporter plasmid in which p53 DNA binding elements were situated upstream of the CAT gene (Kern et al., 1992) . Reporter plasmids were introduced into cells either by electroporation (Ad5 E1 HEK 293, Ad12 E1 HER2, Ad12 E1 HER10 and COS) or lipofection (Ad5 HER911, A549 and Ad12 54K MEF G). (a) Electroporation. Con¯uent cells were detached from the substratum with trypsin, pelleted and resuspended in HEPES-buered DMEM containing 8% FCS (100 ml). DNA (5 mg/con¯uent 6 cm tissue culture dish) was suspended in 50 ml of water, to which 50 ml of twice concentrated DMEM was added. The DNA/ cell mixture was placed in a BioRad Gene Pulser cuvette and electroporated at 220 V and extended 990 mFD. Cells were replated on 6 cm dishes. (b) Lipofection. Twenty-four hours prior to transfection 4610 5 ± 10 6 exponentially growing cells were inoculated onto a 6 cm tissue culture dish so that they would reach about 70% con¯uency by the time of transfection. Transfection solution was prepared by adding lipofectAMINE transfection reagent (30 ml) to HEPESbuered DMEM (900 ml). DNA (5 mg) was added, mixed and incubated at room temperature for 30 min. Washed cells were incubated with the transfection mixture for 6 h before replating in complete medium.
Transfected cells were harvested at appropriate times and CAT activity measured using a Boehringer Mannheim CAT Elisa kit. Luciferase activity was assayed by the protocol described by Huen et al. (1995) . Brie¯y, a luciferase construct with the gene linked to an SV40 promoter (Promega) was transfected into cells. After harvesting cells were solubilized in CAT lysis buer. Cell debris was removed by centrifugation and 50 ml of supernatant was mixed with luciferase assay reagent (100 ml) (Promega). Light emission was measured immediately in a Berthold luminometer.
Synthetic peptides
Two synthetic peptides, comprising amino acids 219-233 (1508) and 205-221 (1507) of the Ad5 and Ad12 larger E1B proteins respectively linked to a penetratin sequence, were prepared using standard f-moc procedures. The amino acid sequences of the peptides were as follows: 1507 ± ERQI-KIWFQNRRMRMQGMPGVVGLDGITF and 1508 ± ER-QIKIW FQNR RM KWK KMSM INMW PGV LGMD GBV. Peptides were puri®ed by HPLC using Vydac C 18 columns eluted with gradients (0 ± 100%) of acetonitrile containing 0.1% TFA. Peptides were freeze-dried, redissolved in water (10 mg/ml) and added to tissue culture medium to give a ®nal concentration of 100 mg/ml. Peptide 1507 was also synthe-sized with an FITC moiety located at the C terminus. This was puri®ed in the same way but was protected from light as much as possible.
Analytical methods
For Western blotting analysis cells were rinsed with cold saline, harvested, and solubilized in 9 M urea 50 mM Tris HCl 7.4 0.15 Mb-mercaptoethanol. Aliquots containing equal amounts of protein (generally 10 or 50 mg) were fractionated by polyacrylamide gel electrophoresis in the presence of SDS. Proteins were electrophetically transferred to nitrocellulose membranes. Antigens were detected using appropriate antibodies (see below) and visualized by ECL (Amersham). Immunoprecipitation was essentially as described previously . Immunoprecipitated proteins were fractionated by SDS ± PAGE and co-immunoprecipitated (i.e. interacting) components detected by Western blotting using appropriate antibodies.
Antibodies
Ad5 E1B 58K and Ad12 E1B 54K proteins were immunoprecipitated or detected in Western blotting or immuno¯uorescence experiments using the monoclonal antibodies 2A6 (a generous gift from Professor Arnold Levine, Princeton) or XPH9 (Merrick et al., 1991) respectively. p53 was detected on Western blots using the rabbit antibody CM1 (a generous gift from Dr Carol Midgley and Professor David Lane, Dundee) and in immunofluorescence using the monoclonal antibody 1801.
Immuno¯uorescence
Cells were grown on glass multiwell slides. FITC-labelled peptide 1507 was added at a concentration of 100 mg/ml during the study of peptide stability. During the other studies peptide 1507 was added to cells (100 mg/ml in culture medium) for the times indicated. Cells were ®xed in paraformaldehyde (4% in PBS) for 30 s and permeabilized with acetone at 7208C (10 min). Fixed cells were stored at 7208C. For staining, cells were warmed to room temperature and non-speci®c binding sites were blocked in blocking buer (20% v/v heat inactivated goat serum, 0.2% BSA w/v and 0.1% sodium azide in PBS) for 30 min. Cells were immunostained by diluting the appropriate antibody in the above blocking buer (1801 1/10, XPH9 1/10, 2A6 1/10, CM1 1/1000). Cells were incubated for 60 min in a humid box at 378C. The antibody was removed by washing the slides twice in PBS for 15 min. FITC and TRITC-labelled anti-species antibody was diluted into blocking buer (1/40) before incubating for 60 min at 378C. Again, the antibody was removed by washing the slides twice in PBS for 15 min. Nuclei were visualized by DAP1 (0.1 mg/ml) staining. The slides were mounted in the presence of DABCO (2% 1,4-diazabicyclo-[2.2.2] octane in 80% glycerol/PBS). Cells were viewed by confocal microscopy using a Zeiss Axiphot uorescence microscope. Images were recorded with the biovision software package (ImproVision) and a low-light level video camera. The channels were recorded independently and pseudo-colour images generated and superimposed with Adobe Photoshop 3.0 software.
Detection of DNA synthesis in cells by immuno¯uorescence microscopy
Twenty-four hours prior to labelling Ad5 E1 HEK 293 cells with BrdU, cells grown on glass multiwell slides were incubated with 100 mg/ml of peptide 1508. Cells were then incubated with 50 mM BrdU for 30 min. Cells were washed brie¯y in PBS, ®xed in 4% para-formaldehyde (in PBS) at room temperature for 8 min, followed by permeabilization in 0.2% Triton X-100 for 5 min. Slides were then incubated in blocking buer (as above) for 30 min at room temperature and then with a rabbit anti-p53 polyclonal antibody (CM-1) for 2 h at 378C in a humidi®ed box. Cells were washed with PBS (2615 min) and subsequently incubated with an antirabbit TRITC-labelled antibody (Sigma) for 2 h prior to two further washes with PBS. After the ®nal washing step, the cells were re-®xed in 4% para-formaldehyde in PBS, prior to incubating slides in 4 M HCl for 30 min at room temperature. After washing in PBS, a FITC-labelled anti-BrdU mouse monoclonal antibody (Becton Dickinson) was added for 2 h at 378C in a humidi®ed box. After washing with PBS, including a ®nal wash containing DAPI (0.1 mg/ml) the slides were mounted in DABCO/glycerol and antigens visualized bȳ uorescence.
